Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Analytics

Biotechnology

Ambagon Therapeutics

Scott Clarke

Jinxia Nancy Deng

Taggra Jackson

Michelle Pazmino

Donna Olivia Debets

Paul Hollenbach

Meredith Kuo

Loes Stevers

Laura Demmers

Karolina Kaminska

Galen Miley

Ceri Zwart

Tom van de Wijngaart

Rao Kolluri

Eline Sijbesma

Rens de Vries

Willem van den Hout

Tanja Meyer

Zhen Zhang

Thomas Marty

Neil Richardson

Maarten Altelaar

Christian Ottmann

Scientific Research Team

Directors Team

Scientific Advisory Team

Leadership Team

Teams at Ambagon Therapeutics

Scientific Research Team

Directors Team

Scientific Advisory Team

Leadership Team